-
KOSPI 2577.27 -2.21 -0.09%
-
KOSDAQ 722.52 -7.07 -0.97%
-
KOSPI200 341.49 +0.02 +0.01%
-
USD/KRW 1396 -2.00 0.14%
HDAC6 inhibitor
Search results
-
HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...
May 19, 2023 (Gmt+09:00)
